Follow the 카이노스메드 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 카이노스메드 has logged 46 public disclosures. The latest transaction was disclosed on 18 June 2024 (Other). Among the most active insiders: 이기섭. Every trade is free.
46
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
39 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Kainos Medicine operates in the healthcare and pharmaceutical sector, listed on the XKRX. The company focuses on developing innovative medical solutions.